论文部分内容阅读
目的:研究小儿呼吸系统感染的临床治疗方法和效果。方法:搜集2012年7月-2013年7月我院接收的小儿呼吸系统感染62例患儿,随机分为甲组和乙组。对甲组31例进行常规治疗,对乙组31例进行常规治疗的基础上应用匹多莫德。观察甲组和乙组的临床效果,并比较。结果:乙组治疗有效率高于甲组,感染次数少于甲组,病程短于甲组,差异显著,有统计学意义(P<0.05)。结论:小儿呼吸系统感染临床治疗时应用匹多莫德,治疗效果较好,复发较少,值得推广。
Objective: To study the clinical treatment of pediatric respiratory infections and its effects. Methods: From July 2012 to July 2013, 62 infants with respiratory infections in our hospital were collected and divided into two groups randomly. A group of 31 cases of conventional treatment, B group 31 cases of conventional treatment based on the application of Pidotimod. The clinical effects of group A and group B were observed and compared. Results: The effective rate of treatment in group B was higher than that in group A, the number of infection was less than that in group A, and the duration of disease was shorter than that in group A, with significant difference (P <0.05). Conclusion: Pidotimod is used in clinical treatment of pediatric respiratory infection. The treatment effect is better and relapse is less, which is worthy of popularization.